Oscar Health (OSCR) Set to Release Quarterly Earnings on Thursday

Key Points

• Oscar Health is expected to report Q3 2026 results before the market opens on November 5. Analysts estimate a loss of $0.1438 per share on $4.69 billion in revenue.
• The company’s previous quarter exceeded expectations, with $1.10 in earnings per share versus a $0.40 consensus estimate and revenue of $4.88 billion, up 70.4% year over year.
• Oscar Health shares opened at $30.39, down 3.1%, while analysts maintain an average “Hold” rating and a consensus price target of $34.90.

Oscar Health (NYSE:OSCR - Get Free Report) will likely be posting its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect the company to announce earnings of ($0.1438) per share and revenue of $4.69 billion for the quarter. Parties are encouraged to explore the company's upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:00 AM ET.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.70. The company had revenue of $4.88 billion for the quarter, compared to analysts' expectations of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. Oscar Health's revenue for the quarter was up 70.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.89) earnings per share. On average, analysts expect Oscar Health to post $1.83 EPS for the current fiscal year and $2.22 EPS for the next fiscal year.

Oscar Health Stock Down 3.1%

Shares of NYSE:OSCR opened at $30.39 on Thursday. The firm has a market cap of $9.38 billion, a P/E ratio of 21.71, a P/E/G ratio of 0.34 and a beta of 2.47. Oscar Health has a 12-month low of $10.69 and a 12-month high of $35.01. The business has a fifty day simple moving average of $31.74 and a 200 day simple moving average of $23.45. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21.

Analysts Set New Price Targets

OSCR has been the subject of a number of analyst reports. Stephens restated an "equal weight" rating and set a $34.00 price objective on shares of Oscar Health in a research report on Thursday, September 17th. Weiss Ratings raised shares of Oscar Health from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Thursday, October 8th. Zacks Research upgraded shares of Oscar Health from a "hold" rating to a "strong-buy" rating in a report on Monday, July 6th. Bank of America boosted their price target on shares of Oscar Health from $28.00 to $30.00 and gave the stock an "underperform" rating in a research report on Thursday, September 17th. Finally, UBS Group lifted their target price on shares of Oscar Health from $26.00 to $36.00 and gave the stock a "neutral" rating in a research note on Monday, October 12th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $34.90.

Insider Activity

In other news, insider Adam Mcananey sold 9,092 shares of the firm's stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $285,943.40. Following the completion of the sale, the insider owned 209,004 shares of the company's stock, valued at $6,573,175.80. This trade represents a 4.17% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 600,000 shares of Oscar Health stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $30.34, for a total transaction of $18,204,000.00. Following the completion of the sale, the director owned 480,866 shares of the company's stock, valued at $14,589,474.44. This represents a 55.51% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 874,451 shares of company stock worth $26,761,671. Company insiders own 22.64% of the company's stock.

About Oscar Health

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act's health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.